JB
Jade Biosciences, Inc.
JBIO · NASDAQ
$17.89 -7.69% (-$1.49)
1M -24.86%
Market Cap $1.21B
P/E Ratio -
Div. Yield -
ROE 49.11%
Bulios Fair Price
$15.61
12.7% downside
Trenutna cena
$17.89
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica JBIO trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
71 /100
Cheap P/B 2.75x
EV/FFO N/A
P/E N/A
Growth
100 /100
Growing Book val. growth 37.92%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 32.46%
ROIC 37.42%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 14.93x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
22 /100
Unstable Profitable years 0
Beta 1.45x
EPS volatility 66.27%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o JBIO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Tom Frohlich
Employees
55
Headquarters
Waltham
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report